| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |